Evidence map›Paper›PMID 39326174›Full record

ArticleDevelopmental cognitive neuroscience2024

Biospecimens in the HEALthy Brain and Child Development (HBCD) Study: Rationale and protocol.

Elinor L Sullivan, Ryan Bogdan, Ludmila Bakhireva, Pat Levitt, Joseph Jones, Michael Sheldon, Julie M Croff, Moriah Thomason, Jamie O Lo, Leigh MacIntyre and 13 more

Abstract readClinical Trial Protocol
In one paragraph

Article in Developmental cognitive neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Elinor L SullivanDepartments of Psychiatry and Behavioral Neuroscience, Center for Mental Health Innovation, Oregon Health & Science University, Portland, OR, USA. Electronic address: sullivel@ohsu.edu.
Ryan BogdanDepartment of Psychological & Brain Sciences, Washington University in Saint Louis, Saint Louis, MO, USA. Electronic address: rbogdan@wustl.edu.
Ludmila BakhirevaSubstance Use Research and Education (SURE) Center, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA. Electronic address: lbakhireva@unm.edu.
Pat LevittDepartment of Pediatrics, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA; Children's Hospital Los Angeles, Los Angeles, CA, USA.
Joseph JonesUnited States Drug Testing Laboratories, Des Plaines, IL, USA.
Michael SheldonSampled, Piscataway, NJ, USA.
Julie M CroffDepartment of Rural Health, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.
Moriah ThomasonDepartment of Child and Adolescent Psychiatry & Department of Population Health, New York University Langone Health, New York City, NY, USA.
Jamie O LoDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
Leigh MacIntyreMcGill University, Montreal, QC, Canada; Lasso Informatics, Montreal, QC, Canada.
Susmita ShrivastavaBooz Allen Hamilton, McLean, VA, USA.
Leigh-Anne CioffrediDept of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington, VT, USA; Vermont Children's Hospital, Burlington, VT, USA.
Andrea G EdlowDepartment of Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Brittany R HowellFralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA; Department of Human Development and Family Science, Virginia Tech, Blacksburg, VA, USA.
Barbara H ChaiyachatiDept of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; PolicyLab & Clinical Futures, Children's Hospital of Philadelphia, Philadelphia, USA.
Nicole Lashley-SimmsDepartment of Psychological & Brain Sciences, Washington University in Saint Louis, Saint Louis, MO, USA.
Kelly MolloyDepartments of Psychiatry and Behavioral Neuroscience, Center for Mental Health Innovation, Oregon Health & Science University, Portland, OR, USA.
Cris LamUniversity of California, San Diego, San Diego, CA, USA.
Anna M StoermannUniversity of California, San Diego, San Diego, CA, USA.
Thanh TrinhUniversity of California, San Diego, San Diego, CA, USA.
Namasivayam AmbalavananDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
Jenae M NeiderhiserDepartment of Psychology, Penn State University, University Park, PA, USA.
HBCD Biospecimens Workgroup

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-income and Homeless Populations and Testing Targeted InterventionsU54GM115516 · NIGMS · MAINEHEALTH · PI CLIFFORD JAMES ROSEN · 2017 to 2026
$51.6M
The Healthy Brain and Child Development National Consortium Administrative CoreU24DA055325 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHRISTINA CHAMBERS, CHARLES Alexander NELSON · 2021 to 2026
$40.8M
Healthy Brain and Child Development National Consortium Data Coordinating CenterU24DA055330 · NIDA · WASHINGTON UNIVERSITY · PI ANDERS M DALE, Damien A Fair · 2021 to 2026
$34.6M
5/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) ConsortiumU01DA055344 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel, Weili Lin · 2021 to 2026
$13.9M
6/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium VanderbiltU01DA055347 · NIDA · VANDERBILT UNIVERSITY · PI Laurie E Cutting, Sarah Scheiderich Osmundson · 2021 to 2026
$12.7M
5/24 Healthy Brain and Child Development National ConsortiumU01DA055353 · NIDA · BOSTON CHILDREN'S HOSPITAL · PI Michelle A Bosquet Enlow, Patricia Ellen Grant · 2021 to 2026
$12.1M
4/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) ConsortiumU01DA055342 · NIDA · CINCINNATI CHILDRENS HOSP MED CTR · PI STEPHANIE L MERHAR, JENNIFER J. VANNEST · 2021 to 2026
$11.9M
HEALthy Brain and Child Development Study at UAB and UAU01DA055322 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Rajesh K Kana, Cassandra R. Newsom · 2021 to 2026
$11.2M
23/24 Healthy Brain and Child Development National ConsortiumU01DA055367 · NIDA · WASHINGTON UNIVERSITY · PI RYAN H BOGDAN, CYNTHIA Elise ROGERS · 2021 to 2026
$10.8M
7/24 Healthy Brain and Child Development National ConsortiumU01DA055350 · NIDA · JOHNS HOPKINS UNIVERSITY · PI JAMES J. PEKAR, ANDREW J. SATIN · 2021 to 2026
$10.7M
14/24 The Healthy Brain & Child Development National ConsortiumU01DA055369 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Gretchen E. Bandoli, CARLA B MARIENFELD · 2021 to 2026
$9.7M
NCATS NIH HHS UL1 TR002369NICHD NIH HHS R01 HD113188NICHD NIH HHS UG1 HD104252NIDA NIH HHS U01 DA055316NIDA NIH HHS U01 DA055322NIDA NIH HHS U01 DA055338NIDA NIH HHS U01 DA055342NIDA NIH HHS U01 DA055344NIDA NIH HHS U01 DA055347NIDA NIH HHS U01 DA055349NIDA NIH HHS U01 DA055350NIDA NIH HHS U01 DA055353NIDA NIH HHS U01 DA055354NIDA NIH HHS U01 DA055355NIDA NIH HHS U01 DA055357NIDA NIH HHS U01 DA055358NIDA NIH HHS U01 DA055359NIDA NIH HHS U01 DA055360NIDA NIH HHS U01 DA055361NIDA NIH HHS U01 DA055362NIDA NIH HHS U01 DA055363NIDA NIH HHS U01 DA055365NIDA NIH HHS U01 DA055366NIDA NIH HHS U01 DA055367NIDA NIH HHS U01 DA055369NIDA NIH HHS U01 DA055370NIDA NIH HHS U01 DA055371NIDA NIH HHS U24 DA055325NIDA NIH HHS U24 DA055330NIGMS NIH HHS U54 GM115516
6 · The paper itself

Abstract

The HEALthy Brain and Child Development (HBCD) Study, a multi-site prospective longitudinal cohort study, will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early childhood. The longitudinal collection of biological samples from over 7000 birthing parents and their children within the HBCD study enables research on pre- and postnatal exposures (e.g., substance use, toxicants, nutrition), and biological processes (e.g., genetics, epigenetic signatures, proteins, metabolites) on neurobehavioral developmental outcomes. The following biosamples are collected from the birthing parent: 1) blood (i.e., whole blood, serum, plasma, buffy coat, and dried blood spots) during pregnancy, 2) nail clippings during pregnancy and one month postpartum, 3) urine during pregnancy, and 4) saliva during pregnancy and at in-person postnatal assessments. The following samples are collected from the child at in-person study assessments: 1) saliva, 2) stool, and 3) urine. Additionally, placenta tissue, cord blood, and cord tissue are collected by a subset of HBCD sites. Here, we describe the rationale for the collection of these biospecimens, their current and potential future uses, the collection protocol, and collection success rates during piloting. This information will assist research teams in the planning of future studies utilizing this collection of biological samples.

Indexed as

BrainChild DevelopmentAdultChildChild, PreschoolFemaleHumansInfantInfant, NewbornLongitudinal StudiesMaleMulticenter Studies as TopicPregnancyProspective StudiesSpecimen HandlingEnvironmental exposuresHBCD, biospecimens, substance usePrenatal, fetal programming

Identifiers

PMID39326174
PMCPMC11460495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.